Candriam Luxembourg S.C.A. Decreases Holdings in CVS Health Corp (CVS)

Candriam Luxembourg S.C.A. reduced its position in shares of CVS Health Corp (NYSE:CVS) by 4.9% in the third quarter, HoldingsChannel reports. The firm owned 90,762 shares of the pharmacy operator’s stock after selling 4,691 shares during the period. Candriam Luxembourg S.C.A.’s holdings in CVS Health were worth $7,381,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Horan Capital Advisors LLC. lifted its position in shares of CVS Health by 3.2% during the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after acquiring an additional 1,000 shares during the last quarter. Community Bank N.A. lifted its position in shares of CVS Health by 7.3% during the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares during the last quarter. FIL Ltd lifted its position in shares of CVS Health by 13.8% during the 2nd quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock valued at $41,424,000 after acquiring an additional 62,318 shares during the last quarter. Midwest Investment Management LLC lifted its position in shares of CVS Health by 6.2% during the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after acquiring an additional 1,245 shares during the last quarter. Finally, ETRADE Capital Management LLC lifted its position in shares of CVS Health by 3.7% during the 2nd quarter. ETRADE Capital Management LLC now owns 55,653 shares of the pharmacy operator’s stock valued at $4,478,000 after acquiring an additional 1,979 shares during the last quarter. 81.62% of the stock is owned by hedge funds and other institutional investors.

Shares of CVS Health Corp (CVS) opened at $78.78 on Friday. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The stock has a market capitalization of $79,800.00, a price-to-earnings ratio of 16.28, a P/E/G ratio of 1.38 and a beta of 0.90.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same period last year, the company earned $1.64 earnings per share. CVS Health’s quarterly revenue was up 3.5% compared to the same quarter last year. analysts predict that CVS Health Corp will post 5.9 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. CVS Health’s dividend payout ratio is 41.32%.

CVS has been the subject of a number of recent research reports. Jefferies Group increased their price objective on CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Royal Bank of Canada assumed coverage on CVS Health in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price for the company. Oppenheimer restated a “buy” rating and issued a $95.00 target price on shares of CVS Health in a report on Monday, October 9th. Needham & Company LLC restated a “hold” rating on shares of CVS Health in a report on Thursday, October 12th. Finally, SunTrust Banks set a $85.00 target price on CVS Health and gave the company a “buy” rating in a report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $86.66.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.61% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This story was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.com-unik.info/2018/01/13/candriam-luxembourg-s-c-a-decreases-holdings-in-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit